Largest Biotechnology Industry Companies
There are 646 Biotechnology companies.
All industries.
Total Market Cap: $1.22T
Rank | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Average | (646 stocks) | +8.40% | 21.33 | 16.01 | 0.22 | -1.93% | 4.98% | +53.36% | +11.37% | 0.89 | |||||
451 | EDSA | Edesa Biotech Inc | $6.88 | $46M | +9.14% | N/A | 0.18 | N/A | -16.26% | N/A | 75 | +103.49% | $14 | -29.34% | 0.18 |
452 | LVTX | LAVA Therapeutics NV | $1.74 | $46M | N/A | N/A | N/A | N/A | -67.20% | N/A | N/A | N/A | N/A | -30.90% | N/A |
453 | TELO | Telomir Pharmaceuticals Inc | $1.25 | $46M | N/A | N/A | N/A | N/A | -8.07% | N/A | N/A | +1140.00% | $16 | 0.00% | 1.37 |
454 | ATYR | Atyr Pharma Inc | $0.46 | $45M | -20.20% | N/A | N/A | N/A | N/A | N/A | 63 | +517.20% | $2.86 | -36.55% | 1.27 |
455 | ESLA | Estrella Immunopharma Inc | $1.01 | $45M | N/A | N/A | N/A | N/A | -17.96% | N/A | 75 | +1088.12% | $12 | 0.00% | 0.59 |
456 | KALA | Kala Bio Inc | $2.85 | $44M | -46.66% | N/A | N/A | N/A | -58.66% | N/A | N/A | -47.28% | $1.50 | -81.90% | N/A |
457 | LTRN | Lantern Pharma Inc | $3.89 | $44M | +5.65% | N/A | N/A | N/A | -34.52% | N/A | 75 | +414.14% | $20 | -23.75% | 1.85 |
458 | NTRB | Nutriband Inc | $3.06 | $42M | +30.87% | N/A | 370.37 | N/A | -12.40% | N/A | N/A | +390.20% | $15 | -19.26% | 0.73 |
459 | TVGN | Tevogen Bio Holdings Inc | $9.70 | $40M | N/A | N/A | N/A | N/A | -29.23% | N/A | N/A | -79.38% | $2 | 0.00% | 1.39 |
460 | FGEN | FibroGen Inc | $9.71 | $39M | N/A | 0.24 | 65.03 | N/A | -54.45% | N/A | 75 | +342.84% | $43 | -60.10% | 1.37 |
461 | GNTA | Genenta Science SpA | $1.84 | $39M | -2.68% | N/A | N/A | N/A | -20.89% | N/A | N/A | +279.35% | $6.98 | 0.00% | 0.56 |
462 | RNXT | RenovoRx Inc | $0.89 | $38M | N/A | N/A | N/A | N/A | -29.49% | N/A | 75 | +689.27% | $7.03 | 0.00% | 0.84 |
463 | PSTV | Plus Therapeutics Inc | $4.31 | $37M | -25.42% | N/A | 0.97 | 2.45 | -58.73% | N/A | 81 | +735.27% | $36 | -66.59% | N/A |
464 | RADX | Radiopharm Theranostics Ltd | $4.42 | $36M | N/A | N/A | N/A | N/A | N/A | N/A | 81 | +290.26% | $17 | 0.00% | 0.44 |
465 | GBIO | Generation Bio Company | $5.34 | $36M | N/A | N/A | 7.87 | N/A | N/A | N/A | N/A | N/A | N/A | -53.42% | N/A |
466 | GRCE | Acasti Pharma Inc | $2.22 | $36M | N/A | N/A | 2.17 | N/A | -28.33% | N/A | N/A | +163.96% | $5.86 | 0.00% | 0.88 |
467 | MURA | Mural Oncology plc | $2.04 | $35M | N/A | N/A | N/A | N/A | N/A | N/A | N/A | +194.12% | $6 | 0.00% | 0.53 |
468 | ABVC | ABVC BioPharma Inc | $1.36 | $35M | -39.24% | N/A | N/A | N/A | -7.02% | N/A | N/A | +48.53% | $2.02 | -50.87% | 1.10 |
469 | ALGS | Aligos Therapeutics Inc | $5.35 | $33M | N/A | N/A | N/A | N/A | N/A | N/A | 78 | +952.15% | $56 | -61.68% | 2.07 |
470 | LSTA | Lisata Therapeutics Inc | $3.52 | $33M | -14.27% | N/A | 2.71 | 118.40 | -41.46% | N/A | 75 | +13.64% | $4 | -31.54% | N/A |
471 | ATNM | Actinium Pharmaceuticals Inc | $1.03 | $32M | -11.69% | N/A | 6.84 | N/A | -71.12% | N/A | 75 | +385.44% | $5 | -33.68% | 1.60 |
472 | INMB | INmune Bio Inc | $1.30 | $32M | +7.56% | N/A | N/A | N/A | -62.80% | N/A | 81 | +438.46% | $7 | -40.52% | 1.78 |
473 | EVAX | Evaxion Biotech A/S | $3.32 | $32M | N/A | N/A | 3.57 | N/A | -21.06% | N/A | 81 | +238.86% | $11 | -60.27% | 0.79 |
474 | BOLD | Boundless Bio Inc | $1.40 | $31M | N/A | N/A | N/A | N/A | N/A | N/A | 50 | +185.71% | $4 | 0.00% | 1.18 |
475 | DARE | Dare Bioscience Inc | $2.08 | $30M | -36.35% | N/A | 1.27 | N/A | -34.58% | N/A | 83 | +364.90% | $9.67 | -33.27% | 0.50 |
476 | GRDX | Entero Therapeutics Inc | $4.95 | $30M | -79.78% | N/A | N/A | N/A | -22.06% | N/A | N/A | N/A | N/A | -86.37% | N/A |
477 | APLM | Apollomics Inc - Class A | $13.96 | $30M | N/A | N/A | N/A | N/A | N/A | N/A | N/A | -85.67% | $2 | 0.00% | 0.43 |
478 | SNTI | Senti Biosciences Inc | $0.95 | $30M | N/A | N/A | N/A | N/A | N/A | N/A | 81 | +1083.21% | $11 | -60.57% | 1.46 |
479 | NNVC | NanoViricides Inc | $1.34 | $29M | -12.51% | N/A | N/A | N/A | -25.41% | N/A | 75 | +347.76% | $6 | -18.86% | 1.08 |
480 | HYPD | Eyenovia Inc | $3.53 | $29M | -41.24% | N/A | N/A | N/A | -50.59% | N/A | 75 | +60.06% | $5.65 | -61.69% | 1.64 |
481 | BRNS | Barinthus Biotherapeutics Plc. | $0.68 | $28M | N/A | N/A | N/A | N/A | N/A | N/A | 75 | +708.82% | $5.50 | -45.62% | 0.70 |
482 | IGC | IGC Pharma Inc | $0.28 | $28M | -18.91% | N/A | N/A | N/A | -19.83% | N/A | 75 | +1441.53% | $4.25 | -29.20% | 0.66 |
483 | SKYE | Skye Bioscience Inc | $0.71 | $27M | -21.69% | N/A | N/A | N/A | N/A | N/A | 75 | +983.63% | $7.71 | -55.87% | 1.46 |
484 | DYAI | Dyadic International Inc DE | $0.85 | $27M | -7.16% | N/A | 15.82 | N/A | -21.49% | N/A | 75 | +607.05% | $6 | -24.01% | 0.48 |
485 | VTGN | VistaGen Therapeutics Inc | $0.69 | $26M | -12.57% | N/A | N/A | N/A | N/A | N/A | 50 | +40.14% | $0.97 | -61.94% | 0.97 |
486 | LITS | Lite Strategy Inc | $0.92 | $26M | -11.11% | N/A | 4.62 | 2.22 | -39.80% | N/A | N/A | N/A | N/A | -54.94% | 1.52 |
487 | SER | AgeX Therapeutics Inc | $1.98 | $26M | -28.62% | N/A | N/A | N/A | -70.53% | N/A | 75 | +455.56% | $11 | -48.22% | 0.27 |
488 | TVRD | Cara Therapeutics Inc | $2.58 | $24M | N/A | N/A | N/A | N/A | N/A | N/A | 56 | +221.32% | $8.29 | -65.45% | 0.37 |
489 | MRKR | Marker Therapeutics Inc | $1.35 | $24M | -32.88% | N/A | N/A | N/A | -33.16% | N/A | 75 | +482.96% | $7.87 | -46.94% | 1.17 |
490 | NRSN | NeuroSense Therapeutics Ltd | $0.71 | $24M | -17.43% | N/A | N/A | N/A | -32.25% | N/A | 75 | +821.99% | $6.50 | 0.00% | 0.59 |
491 | NEUP | Neuphoria Therapeutics Inc | $4.31 | $24M | N/A | N/A | N/A | N/A | -72.16% | N/A | 87 | +62.41% | $7 | 0.00% | 1.31 |
492 | PLUR | Pluri Inc | $2.25 | $24M | -24.16% | N/A | 3.63 | N/A | -92.01% | N/A | N/A | +433.33% | $12 | -41.02% | 0.04 |
493 | CRVO | CervoMed Inc | $3.81 | $24M | -22.16% | N/A | N/A | N/A | N/A | N/A | 75 | +411.81% | $20 | -41.08% | 1.25 |
494 | CELU | Celularity Inc - Class A | $0.80 | $23M | N/A | N/A | N/A | N/A | -57.70% | N/A | N/A | +213.87% | $2.50 | -62.11% | 1.36 |
495 | COEP | Coeptis Therapeutics Holdings Inc. Common Stock | $3.35 | $22M | N/A | N/A | N/A | N/A | -36.42% | N/A | N/A | N/A | N/A | -3.48% | N/A |
496 | PTN | Palatin Technologies Inc | $12.25 | $22M | N/A | N/A | 42.92 | N/A | -68.86% | N/A | 83 | +336.73% | $54 | 0.00% | 0.11 |
497 | HOTH | Hoth Therapeutics Inc | $1.10 | $22M | -44.40% | N/A | N/A | N/A | -46.52% | N/A | N/A | N/A | N/A | -50.89% | N/A |
498 | OPT | Opthea Ltd | $3.41 | $22M | N/A | N/A | 6.73 | N/A | N/A | N/A | N/A | N/A | N/A | 0.00% | N/A |
499 | ALLR | Allarity Therapeutics Inc | $1.34 | $21M | N/A | N/A | N/A | N/A | -78.78% | N/A | 75 | +664.93% | $10 | 0.00% | N/A |
500 | VYNE | VYNE Therapeutics Inc | $0.63 | $21M | -49.07% | N/A | N/A | N/A | N/A | N/A | N/A | +216.91% | $2 | -60.49% | 1.12 |